ArticleCureus2026
Patient-Centered Transition to Clean Intermittent Catheterization After a Sacrectomy for Sacral Chordoma: A Case Report and Narrative Review.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sacral chordoma may cause progressive neurological and pelvic organ dysfunction, while definitive surgery can require sacrifice of sacral nerve roots and result in permanent neurogenic bladder. We report a 57-year-old woman with an S2-S4 sacral chordoma presenting with severe lumbosacral pain and voiding dysfunction. Initial imaging demonstrated a 70 × 50 × 42 mm lesion extending into the sacral canal and presacral space. On day three, she underwent a limited decompressive resection of the intraspinal component to relieve root compression and obtain tissue for diagnosis. Histopathology and immunohistochemistry confirmed chordoma. Continued tumor growth was documented, reaching 72 × 51 × 81 mm by week 11. A two-stage procedure was then performed, consisting of endoscopic mobilization of the tumor and pelvic vessels followed by midline S2-S5 sacrectomy. The S1 roots were preserved, whereas the S2-S5 roots were sacrificed. Postoperatively, the patient developed clinically complete bladder atony with painless urinary retention and a bladder volume of 700 mL with 700 mL residual urine. Temporary urethral catheter drainage was used, and an
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.